» Articles » PMID: 31118824

Predictors of Chronic Kidney Disease Among HIV-infected Patients on Highly Active Antiretroviral Therapy at the University of Calabar Teaching Hospital, Calabar, South-South Nigeria

Overview
Publisher Dove Medical Press
Date 2019 May 24
PMID 31118824
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The burden of the people living with human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS) is largely borne by communities in Sub-Saharan Africa. The rate of kidney disease is increasing amongst HIV patients and occurs more often in patients with advanced stage of the disease with lower CD counts and associated with a high rate of morbidity and mortality. The objective of this study is to determine the prevalence and predictors of chronic kidney disease (CKD) amongst HIV patients on highly active antiretroviral therapy (HAART) at the University of Calabar Teaching Hospital, Calabar. This was a cross-sectional study that was carried out over a 4-month period from May to August 2018. In all, a total of 118 patients with HIV on HAART were recruited into the study in a consecutive manner and their serum creatinine measured with the calculation of estimated glomerular filtration rate (eGFR). Other data collected were sex, age, weight, height, body mass index (BMI), waist hip ratio (WHR), packed cell volume, CD4 count etcetera. Data collected were inputted and analyzed with SPSS version 18, and statistical significance was taken to be <0.05. There were more females (69.5%) amongst the HIV participants and the prevalence of CKD was 15.3%. The risk factors seen to be associated with CKD were lower levels of CD4 count below 200 cells/µl, lower PCV, weight, BMI, and eGFR. Also, higher levels of WHR and creatinine were associated with CKD. Factors directly correlated with CKD were weight, BMI and CD4 count levels, while creatinine level was inversely correlated with CKD. However, a logistic regression model showed only creatinine to be a predictor of CKD. HIV patients on antiretroviral therapy, mainly the highly active antiretroviral therapy (HAART) have a relatively high prevalence of CKD of 15.3% and high level of serum creatinine was predictive of CKD in the logistic regression model in our study.

Citing Articles

Chronic kidney disease among people living with HIV on TDF based regimen: A systematic review and meta-analysis.

Yazie T, Shiferaw W, Gebeyehu A, Teshome A, Addisu Z, Belete A PLoS One. 2025; 20(2):e0318068.

PMID: 39913460 PMC: 11801554. DOI: 10.1371/journal.pone.0318068.


Urine kidney injury molecule-1 predicts subclinical kidney disease among persons living with HIV initiating tenofovir disoproxil fumarate-based ART in Zambia.

Chabala F, Siew E, Wester C, Brennan A, Phiri M, Vinikoor M Front Nephrol. 2025; 4():1468409.

PMID: 39834612 PMC: 11743383. DOI: 10.3389/fneph.2024.1468409.


Prevalence and predictors of renal dysfunction among people living with HIV on antiretroviral therapy in the Southern Highland of Tanzania: a hospital-based cross-sectional study.

Mwanjala M, Urio L, Mtebe M Pan Afr Med J. 2022; 41:137.

PMID: 35519167 PMC: 9034560. DOI: 10.11604/pamj.2022.41.137.27025.


Chronic Kidney Disease and Associated Factors Among HIV/AIDS Patients on HAART in Ethiopia.

Manaye G, Abateneh D, Niguse W HIV AIDS (Auckl). 2020; 12:591-599.

PMID: 33116921 PMC: 7585507. DOI: 10.2147/HIV.S276356.


Renal Dysfunction among HIV-Infected Patients on Antiretroviral Therapy in Dar es Salaam, Tanzania: A Cross-Sectional Study.

Mwemezi O, Ruggajo P, Mngumi J, Furia F Int J Nephrol. 2020; 2020:8378947.

PMID: 33101732 PMC: 7568141. DOI: 10.1155/2020/8378947.


References
1.
Shahinian V, Rajaraman S, Borucki M, Grady J, HOLLANDER W, Ahuja T . Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis. 2000; 35(5):884-8. DOI: 10.1016/s0272-6386(00)70259-9. View

2.
Szczech L, Gange S, van der Horst C, Bartlett J, Young M, Cohen M . Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002; 61(1):195-202. DOI: 10.1046/j.1523-1755.2002.00094.x. View

3.
. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266. View

4.
Ahuja T, Grady J, Khan S . Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol. 2002; 13(7):1889-93. DOI: 10.1097/01.asn.0000019773.43765.bf. View

5.
Agaba E, Agaba P, Sirisena N, Anteyi E, Idoko J . Renal disease in the acquired immunodeficiency syndrome in north central Nigeria. Niger J Med. 2004; 12(3):120-5. View